During Sepsis Awareness Month, MD+DI checked in with Prenosis, which developed Immunix for rating a patient’s chances of sepsis, 30-day mortality, elongated hospital stay, and 30-day readmission to the hospital.
The company is recalling thousands of embolization devices because there is a risk of the delivery system's wires and tubes fracturing and breaking off during placement, retrieval, or movement of the device.